| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |